24 Amendments of Dolors MONTSERRAT related to 2023/2075(INI)
Amendment 4 #
Motion for a resolution
Citation 1 a (new)
Citation 1 a (new)
– having regard to its resolution on “Strengthening Europe in the fight against cancer”, adopted on 16 February 2022,
Amendment 5 #
Motion for a resolution
Citation 1 b (new)
Citation 1 b (new)
– having regard to its resolution of 12 July 2023 on the COVID-19 pandemic: lessons learned and recommendations for the future’ (2022/2076(INI)),
Amendment 85 #
Motion for a resolution
Recital D
Recital D
D. whereas the increasing burden of NCDs and the health needs of ageing populations represent challenges to the health systems of the Member States, which require the development of specific NCD prevention, detection and treatment policies contributing to healthy ageing;
Amendment 87 #
Motion for a resolution
Recital D
Recital D
D. whereas the increasing burden of NCDs on individuals and societies and the health needs of ageing populations, 40% of which live with multimorbidity, represent challenges to the healthcare systems of the Member States;
Amendment 163 #
Motion for a resolution
Recital G a (new)
Recital G a (new)
Ga. whereas people living with one or more NCDs were one of the most severely affected population groups during the COVID-19 pandemic; whereas investment in NCD prevention and management remains limited, despite access to care, essential complications screening and diagnosis being severely disrupted during the COVID-19 pandemic, potentially leading to severe complications over the longer term;
Amendment 262 #
Motion for a resolution
Paragraph 3 a (new)
Paragraph 3 a (new)
3a. Acknowledges that social, economic, cultural, and environmental determinants of health, and health inequities increase the risk of NCDs and underlines the need to create favourable conditions that address these factors; emphasizes the importance of a more robust implementation of the Health in All Policies principle, in dialogue with the public health community, and with thorough consideration of the health impacts of sectoral policies;
Amendment 270 #
Motion for a resolution
Paragraph 3 b (new)
Paragraph 3 b (new)
3b. Underlines that the ‘One Health’ approach should guide the reduction and use optimisation of antimicrobials, to prevent and fight the Antimicrobial Resistance (AMR) as well as the development of new medicines, including antimicrobial agents;
Amendment 273 #
Motion for a resolution
Paragraph 4
Paragraph 4
4. Acknowledges that tobacco use was responsible for 1.6 million deaths in Europe in 2019 and is a high risk factor for developing NCDs such as cancer, cardiovascular diseases and chronic respiratory diseases and calls for an harmonisation in the definitions of tobacco and related products across EU legislation;
Amendment 319 #
Motion for a resolution
Paragraph 5 – point b a (new)
Paragraph 5 – point b a (new)
ba. publish annual reports on the progress towards achieving a tobacco-free generation by 2040;
Amendment 383 #
Motion for a resolution
Paragraph 7 a (new)
Paragraph 7 a (new)
7a. Recalls the Commission and Member States to enhance the provision of better information to consumers including moderate and responsible drinking information through digital labelling;
Amendment 433 #
Motion for a resolution
Paragraph 8 – point b a (new)
Paragraph 8 – point b a (new)
ba. promote behavioural changes via communication, and mass media campaigns for healthy diets and encourage public food procurement and service policies for healthy and sustainable diets;
Amendment 453 #
Motion for a resolution
Paragraph 8 a (new)
Paragraph 8 a (new)
8a. Highlights that the Mediterranean diet is recognized as a healthy, balanced diet that plays a protective role in the primary and secondary prevention of the main chronic degenerative diseases;
Amendment 500 #
Motion for a resolution
Paragraph 12
Paragraph 12
12. Stresses that per- and polyfluorinated alkyl substances (PFAS) can lead to health problems such as diabetes1a, obesity and cancer16 ; calls on the Commission to implement the PFAS restriction proposal submitted to European Chemicals Agency on 13 January 202317 ; _________________ 1a GlobalData Healthcare, 'High exposure to PFAS more than doubles risk of developing diabetes in women'. Clinical Trials Arena 16 European Environment Agency, ‘What are PFAS and how are they dangerous for my health?’. 17 European Chemicals Agency, ‘ECHA publishes PFAS restriction proposal’, 2023.
Amendment 540 #
Motion for a resolution
Paragraph 14
Paragraph 14
14. Encourages the Commission and the Member States to achieve the UN Sustainable Development Goals that target communicable diseases in order to promote the prevention of NCDs such as cancer related to infectious diseases; welcomes vaccination programmes, in this regard such as in the fight against human papillomavirus transmission; cluding the adoption of gender-neutral human papillomavirus (HPV) vaccinations for all adolescents and young adults, in the fight against HPV;
Amendment 573 #
Motion for a resolution
Paragraph 15 a (new)
Paragraph 15 a (new)
15a. Recommends EU funding support for pan-European public health literacy initiatives, such as the suggestion of creating a European Atlas of Early Warning Signs for Cancer, building on the model for cancer prevention created by the European Code Against Cancer;
Amendment 624 #
Motion for a resolution
Paragraph 18
Paragraph 18
18. Stresses that nurses, doctors, general practitioners and other primary care professionals , as well as pharmacists, have a significant role in referring patients for diagnostic tests and treating NCDs; encourages the Member States to offer training to healthcare professionals to better identify high-risk individuals and treat NCDs;
Amendment 629 #
Motion for a resolution
Paragraph 18 a (new)
Paragraph 18 a (new)
18a. Stresses the importance of providing multidisciplinary holistic care, both preventive and curative, in which patients' lifestyle and dietary habits are improved and which allows for the personalisation of a patient's lifestyle and treatment system that facilitates maximum sustainability and health options, as offered by Integrative Medicine, scientifically recognised, approved by public health authorities and practiced by healthcare professionals; urges the Commission and Member States to prioritise the regulation, research, teaching and implementation of science- based Integrative Medicine in all the EU national healthcare systems;
Amendment 638 #
Motion for a resolution
Paragraph 18 b (new)
Paragraph 18 b (new)
18b. Recommends urgent actions, including a Commission level study on the current status and impacts of the EU’s health workforce shortage and increased investment in its availability measuring and mapping exercises at the EU level; supports the proposed actions by the European Commission to address the pan-European problem of medicines shortages, encourage re-shoring of production; recognises that health workforce shortage can be a worsening factor in the response to future health emergencies and therefore recommends that the European Health Emergency Response Authority (HERA) be provided with explicit mandate to map and propose remedial measures to combat health workforce shortage;
Amendment 642 #
Motion for a resolution
Paragraph 18 c (new)
Paragraph 18 c (new)
18c. Encourages the Commission and Member States to embed engagement with patient organisations and people living with NCDs into all activities and initiatives related to the design and implementation of prevention and care activities;
Amendment 646 #
Motion for a resolution
Paragraph 18 d (new)
Paragraph 18 d (new)
18d. Emphasises the need to deploy person-centred and fully integrated care across the entire chronic diseases care pathway and to strengthen community and priority care, with a focus on chronic diseases requiring access to care across specialties and care levels such as diabetes;
Amendment 647 #
Motion for a resolution
Paragraph 18 e (new)
Paragraph 18 e (new)
18e. Highlights the valuable role of community pharmacies and recognises their valuable contribution in continuously providing an essential and quality service to support the treatment of NCDs and keep the general public informed; stresses that pharmacists are an independent, reliable and trustworthy source of information; suggests that pharmacists play a more active role in pharmacovigilance activities to assess and monitor the effectiveness of medicines and invites Member States to include them in their health, care and research programmes; calls for greater recognition of pharmacies in rural areas, which enable such areas to retain their populations and ensure the well-being of citizens;
Amendment 671 #
Motion for a resolution
Paragraph 19 a (new)
Paragraph 19 a (new)
19a. Invites the Commission and Member States to promote basic and clinical research on the use and potential beneficial effects of medical ozone for its complementary use in prevention and treatment of different NCDs;
Amendment 680 #
Motion for a resolution
Paragraph 19 b (new)
Paragraph 19 b (new)
19b. Emphasizes that the results of NCDs treatment can be hampered by malnutrition, therefore optimal nutritional care is an essential part of NCDs care; calls on the Commission and Member States to develop recommendations for incorporating clinical nutrition into all aspects of NCDs care, including treatment, support and research;
Amendment 807 #
Motion for a resolution
Paragraph 26 a (new)
Paragraph 26 a (new)
26a. Acknowledges that many chronic diseases can lead to organ failure for which transplantation is the best therapy; notes that the EU action plan on organ donation and transplantation (2009-2015) resulted in a considerable increase in organ donation and transplantation in the EU over its period of implementation; calls on the Commission to establish a 2nd EU action plan on organ donation and transplantation during the 2024-2027 mandate;